Clinical Trials Browser

Observational × Triple Negative Breast Neoplasms × Breast × Clear all

NCT04314401 2026-03-18

National Cancer Institute "Cancer Moonshot Biobank"

BreastDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05742269 2026-03-13

MIMIR-mTNBC

Triple Negative Breast Neoplasms

NCT07084571 2026-03-12

FORTITUDE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06709651 2026-03-04

MINA

Triple Negative Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT04981119 2026-02-13

BASECAMP-1

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05914961 2026-02-12

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

Triple Negative Breast Neoplasms

NCT05115474 2026-02-09

Study of Screening Brain MRIs in Stage IV Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07327489 2026-01-08

ELEPHAS-05

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06774027 2025-12-18

ENCORE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04438681 2025-12-04

INSTIGO

Active not recruiting

Triple Negative Breast Neoplasms

NCT07260188 2025-12-03

PDO-Neo01

Triple Negative Breast Neoplasms

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03586297 2025-10-14

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT07211451 2025-10-08

Axillary Nodal Burden in HER2+ and TNBC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06087120 2025-09-23

BRAVA

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05404321 2025-09-22

TRIPLEX

Triple Negative Breast Neoplasms

NCT03165487 2025-08-22

Comparison of the Breast Tumor Microenvironment

Active not recruiting

Triple Negative Breast Neoplasms

NCT05435352 2025-07-30

PEAR-TNBC

Triple Negative Breast Neoplasms

NCT07073755 2025-07-18

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06885424 2025-07-15

DESCENT-1

Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05396612 2025-07-08

Role of the Immune Environment in Response to Therapy in Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05891197 2025-07-01

START

BreastGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07018427 2025-06-12

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06991790 2025-05-28

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Triple Negative Breast Neoplasms

NCT06965361 2025-05-16

TIL; PD1; PDL1

Triple Negative Breast Neoplasms

NCT05877859 2025-05-14

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06476119 2025-04-23

OPTImaL

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04068623 2025-02-19

PERCEPTION

Triple Negative Breast Neoplasms

NCT06798506 2025-01-29

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06230185 2025-01-07

B-STRONGER-I

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT03981705 2024-12-27

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04803084 2024-11-20

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06692725 2024-11-20

NacTNBC

Triple Negative Breast Neoplasms

NCT06681064 2024-11-08

BELIEVE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06646263 2024-10-17

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Enrolling by invitation

Triple Negative Breast Neoplasms

NCT06396754 2024-10-02

AIDOBE

Not yet recruiting

Triple Negative Breast Neoplasms

NCT05099978 2024-09-04

A-TRAIN

BreastGynecologicHead & Neck

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04835597 2024-08-26

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Triple Negative Breast Neoplasms

NCT05111067 2024-08-21

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

Triple Negative Breast Neoplasms

NCT05169853 2024-08-20

Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer

Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Not yet recruiting

Hypersensitivity, Triple Negative Breast Neoplasms

NCT06418139 2024-05-16

PEMCLOCK

Not yet recruiting

Triple Negative Breast Neoplasms

NCT06409221 2024-05-10

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

Enrolling by invitation

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06182306 2024-04-03

PEAR-MET

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06309459 2024-03-13

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

Triple Negative Breast Neoplasms

NCT05071677 2023-08-09

Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT05730010 2023-08-03

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Breast Neoplasms, Triple Negative Breast Neoplasms